PDCD1 and neoplasm: Based on this, multi-target combination strategies have been used for tumor treatment, such as PD-1/PD-L1 inhibitor combined with CTLA-4 inhibitor and PD-1 inhibitor combined with anti–LAG-3 (74, 337).